GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **2326 - 2350** of **4050** in total

« First

‹ Prev

…

90

91

92

93

94

95

96

97

98

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgA	Patient 2	3	mild	G51872EK	734
IgG	Patient 2	3	mild	G51872EK	72
IgM	Patient 2	3	mild	G51872EK	338
IgA	Patient 3	-180	mild	G51872EK	282
IgA	Patient 3	11	mild	G51872EK	443
IgG	Patient 3	-180	mild	G51872EK	72
IgM	Patient 3	-180	mild	G51872EK	122
IgA	Patient 3	4	mild	G51872EK	467
IgG	Patient 3	11	mild	G51872EK	63
IgG	Patient 3	4	mild	G51872EK	61
IgM	Patient 3	11	mild	G51872EK	104
IgM	Patient 3	4	mild	G51872EK	115
IgA	Patient 4	12	mild	G51872EK	616
IgG	Patient 4	12	mild	G51872EK	59
IgM	Patient 4	12	mild	G51872EK	169
IgA	Patient 1	10	moderate	G52880ZN	416
IgA	Patient 1	22	moderate	G52880ZN	359
IgA	Patient 1	6	moderate	G52880ZN	346
IgG	Patient 1	10	moderate	G52880ZN	23
IgG	Patient 1	22	moderate	G52880ZN	24
IgM	Patient 1	10	moderate	G52880ZN	40
IgM	Patient 1	22	moderate	G52880ZN	50
IgA	Patient 2	15	mild	G52880ZN	331
IgA	Patient 2	24	mild	G52880ZN	371
IgG	Patient 2	15	mild	G52880ZN	32